Juvenile Idiopathic Arthritis: clinical manifestation and treatment
Keywords:
Joints, Juvenile Arthritis, Synovial Fluid, PediatricsAbstract
Juvenile idiopathic arthritis is the most common rheumatic disease in children. It is a chronic and degenerative disease, with an unknown etiology; that can leave multiple sequels in the pediatric population. There are seven conditions defined by 2001 International League of Associations for Rheumatology: Systemic Arthritis, Oligoarthritis, Arthritis with positive rheumatoid factor or negative rheumatoid factor, enthesitis-related arthritis and undifferentiated arthritis; distinct in clinical, pathogenetic and evolutionary aspects. This disease is characterized by an alteration on the regulation of the innate immune system with a lack of autoreactive lymphocytes T and autoantibodies. Continuous inflammation stimulates the rapid and premature closure of the growth cartilage causing bone shortening.
To arrive at the diagnosis, it is only necessary to have a good medical history and physical exam, since there are no laboratory test sensitive enough to help us. Drugs such as methotrexate and tumor necrosis factor inhibitors have come to modify the evolution of the disease and improve the quality of life of these patients.
References
2. Arreguin-Reyes R, Vale-Leal J, Lozano Rentería L, Medina-Valenton E, Álvarez Bastidas L. Descripción de una cohorte de pacientes de artritis idiopática juvenil en el estado de Sonora, México. Revista Colombiana de Reumatología [Internet]. 2016 Oct;23(4):236-41. Available from: http://dx.doi.org/10.1016/j.rcreu.2016.06.004
3. Ma T Brieva Herrero. Manejo de artritis idiopática juvenil sistémica en pediatría con agentes biológicos a propósito de. FARMACIA HOSPITALARIA [Internet]. 2014 Jul 1; (4):384-5. Available from: http://dx.doi.org/10.7399/fh.2014.38.4.7368
4. Y. Wu E, Bryan A, Rabinovich C. Artritis Idiopatica Juvenil. In: Kliegman R, Stanton B, St Geme III J, Schor N, ed. by. Nelson Tratado de Pediatría. 20th ed. Barcelona: El Sevier; 2015. p. 1213-1224
5. Grom, A. Juvenil idiopathic arthritis: Epidemiology and immunopathogenesis. Uptodate. [Internet]. [Consultado el 21 septiembre 2019]. 2018;12-3. Disponible en: https://ezproxy.ucimed.com:2055/contents/juvenile-idiopathic-arthritis-epidemiology-andimmunopathogenesis?search=artritis%20idiopatica%20juvenil&source=search_result&selectedTitle=7~150&usage_type=default&display_rank=7
6. Kimura, Y. Systemic juvenile idiopathic arthritis: Clinical manifestations and dignosis. Uptodate. [Internet]. [Consultado el 21 septiembre 2019]. 2018;12-7. Disponible en: https://ezproxy.ucimed.com:2055/contents/systemic-juvenile-idiopathic-arthritis-clinicalmanifestations-anddiagnosis?search=artritis%20idiopatica%20juvenil&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1
7. Imboden John B, Hellmann David B, Stone John H. Current Diagnosis & Treatment Rheumatology. 3rd ed. Estados Unidos: Mc Graw Hill; 2013
8. Espada G. Artritis idiopática juvenil. Parte 1: Diagnóstico, patogenia y manifestaciones clínicas. Arch Argent Pediatr. 2009;107(5) 441-448
9. Klein-Gitelman, M. Clasification of juvenile arthritis. Uptodate. [Internet]. [Consultado el 21
septiembre 2019]. 2017;21-9. Disponible en:
https://ezproxy.ucimed.com:2055/contents/classification-of-juvenilearthritis? search=artritis%20idiopática%20juvenil&source=search_result&selectedTitle=2~150&us age_type=default&display_rank=2#H2
10. Vega Aponte C, Rodríguez Chacón J, Martínez Donate J, Ríos la Orden J. Un paciente con artritis idiopática juvenil. Rev Pediatr Aten Primaria. 2014;16:e147-e150
11. Job-Deslandre C. Artritis idiopáticas juveniles. EMC – Aparato Locomotor [Internet]. 2015 Dec;48(4):1-15. Available from: http://dx.doi.org/10.1016/S1286-935X(15)74983-X
12. Esquivel Rodriguez, A. and Arguedas Arguedas, O. (2015). Artrocentesis en el manejo de la Artritis Idiopática Juvenil: La experiencia del Hospital Nacional de Niños ¨Dr. Carlos Saén Herrera¨ en el periodo de enero 2009 a diciembre del 2013. Especialista en Pediatría. Universidad de Costa Rica.
13. Espada G. Artritis idiopática juvenil. Parte 2: Pronóstico y abordaje terapéutico actual. Arch Argent Pediatr. 2009;107(6) 536-541
14. Ariana Morales López (2014) artritis idiopática juvenil, revista médica de costa rica y centroamerica lxxi (609)
15. Bijlsma Johannes WJ, Hachulla Eric. EULAR Textbook on Rheumatic Diseases. 2nd ed.Italy; BMJ; 2015
16. Crayne CB, Beukelman T. Juvenile Idiopathic Arthritis. Pediatric Clinics of North America [Internet] 2018 Aug;65(4):657-74. Available from: http://dx.doi.org/10.1016/j.pcl.2018.03.005
17. Calvo I, Antón J, López Robledillo JC, de Inocencio J, Gamir ML, Merino R, et al. Recomendaciones para el uso de metrotexato en pacientes con artritis idiopatica juvenile. Anales de Pediatría [Internet]. 2016 Mar;84(3):177.e1-177.e8. Available from: http://dx.doi.org/10.16/j.anpedi.2015.05.005
18. Kimura, Y. Systemic juvenile idiopathic arthritis: Treatment. Uptodate. [Internet]. [Consultado el 21 septiembre 2019]. 2019;2-4. Disponible en: https://ezproxy.ucimed.com:2055/contents/systemicjuvenile-idiopathic-arthritistreatment?search=artritis%20idiopatica%20juvenil&source=search_result&selectedTitle=6~150&usage_type=default&display_rank=6
19. Ruiz, O., Gallón, C., González, T. 2017. Síndrome de activación macrofágica como complicación de una artritis idiopática juvenil de tipo sistémico: Reporte de un caso. Cienc innov salud. 4(2):1-5.DOI 10.17081/innosa. 4.2.2630
20. Coto Hermosilla Cecilia, García García Idrian, Díaz Rojo Gisou, Bello Rivero Iraldo, Bermudez Badell Cimara, Valera Puente Gloria et al . Interferón gamma recombinante como alternativa terapéutica en niños con artritis idiopática juvenil. Rev Cubana Pediatr [Internet]. 2010 Mar [citado 2019 Ago 21] ; 82( 1 ). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312010000100001&lng=es
Downloads
Published
Issue
Section
License
The intellectual property of accepted works belongs to their authors, however access to them is totally open and free, so they can be reproduced totally or partially with the only limitation of recognizing the authorship and the source of publication (Revista Medicina Legal de Costa Rica), as long as said exploitation does not have commercial character.
